Alcon Inc. (ETR:2U3)
Germany · Delayed Price · Currency is EUR | Market Cap | 31.35B |
| Revenue (ttm) | 8.54B |
| Net Income (ttm) | 913.66M |
| Shares Out | n/a |
| EPS (ttm) | 1.84 |
| PE Ratio | 34.31 |
| Forward PE | 22.11 |
| Dividend | 0.30 (0.46%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | n/a |
| Average Volume | 1,157 |
| Open | 64.32 |
| Previous Close | 63.64 |
| Day's Range | 64.32 - 64.32 |
| 52-Week Range | 62.10 - 85.94 |
| Beta | n/a |
| RSI | 41.97 |
| Earnings Date | Nov 11, 2025 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]
Financial Performance
In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.
Financial numbers in USD Financial StatementsNews
STAAR Opens 30-Day Window To Seek Higher Bids Than Alcon Deal
(RTTNews) - STAAR Surgical Company (STAA) on Friday announced that it has amended its merger agreement with Alcon (ALC) to launch a 30-day go-shop period through December 6, allowing the company to ac...
STAAR Surgical (STAA) Amends Alcon Merger Agreement with Go-Shop Period
STAAR Surgical (STAA) Amends Alcon Merger Agreement with Go-Shop Period
STAAR Surgical adds 30-day go-shop to Alcon transaction
ALC: Alcon and STAAR Surgical Amend Merger Agreement to Explore Third-Party Proposals
ALC: Alcon and STAAR Surgical Amend Merger Agreement to Explore Third-Party Proposals
STAAR Surgical Announces Amendments to Alcon Merger Agreement
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...
LNSR Reports Q3 Revenue Growth and Updates on Alcon Acquisition
LNSR Reports Q3 Revenue Growth and Updates on Alcon Acquisition
Broadwood Partners Urges STAAR Shareholders to Reject Alcon's Acquisition Bid
Broadwood Partners Urges STAAR Shareholders to Reject Alcon's Acquisition Bid
Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regarding its propo...
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company (NASD...
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
GENEVA--(BUSINESS WIRE)--Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders.
Aristotle Global Equity Advisory Q3 2025 Contributors And Detractors
MonotaRO, the Japanese business-to-business (B2B) e-commerce platform, was the largest detractor during the quarter. Pawn shop operator FirstCash was the top contributor during the quarter. Aggregates...
Alcon (ALC) Moves Forward with STAAR Merger Plans
Alcon (ALC) Moves Forward with STAAR Merger Plans
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) ...
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...
Harding Loevner International Equity ADR Q3 2025 Portfolio Update
The International Equity ADR composite rose 3.0% gross of fees in the second quarter, behind the 7.0% gain of the MSCI ACWI ex US Index. In Communication Services, Tencent delivered a second consecuti...
Alcon (ALC) Faces Shareholder Meeting Delay Amid Merger Talks
Alcon (ALC) Faces Shareholder Meeting Delay Amid Merger Talks
Alcon (ALC) Possibly Revisiting Merger Terms
Alcon (ALC) Possibly Revisiting Merger Terms
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/NY...
ALC: Delayed Stockholder Meeting Raises Concerns Over Alcon's Acquisition Offer
ALC: Delayed Stockholder Meeting Raises Concerns Over Alcon's Acquisition Offer
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NAS...
Alcon (ALC) Delays Staar Merger Meeting to November
Alcon (ALC) Delays Staar Merger Meeting to November
STAAR Surgical (STAA) Faces Shareholder Pushback on Alcon Acquisition
STAAR Surgical (STAA) Faces Shareholder Pushback on Alcon Acquisition
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufact...
Alcon (ALC) Faces Opposition in Proposed Acquisition Deal
Alcon (ALC) Faces Opposition in Proposed Acquisition Deal